Search research articles
Contact Us
Filters
Showing results (1-10 of 14) with videos related to
Page
of 2
Sort By:
Neuroscience Letters
|
June 30, 1986
Rat atriopeptin III alters hypothalamic neuronal activity
J T Haskins, G J Zingaro, R W Lappe
Brain Research
|
May 16, 1988
The development of orientation and direction selectivity in the rabbit visual cortex
A M Grigonis, G J Zingaro, E H Murphy
Proceedings of the National Academy of Sciences of the United States of America
|
November 1, 1988
BRL 34915 (cromakalim) activates ATP-sensitive K+ current in cardiac muscle
M C Sanguinetti, A L Scott, G J Zingaro, et al.
Clinical and Experimental Hypertension (New York, N.Y. : 1993)
|
August 1, 1995
In vivo pharmacology of L-159,913, a new highly potent and selective nonpeptide angiotensin II receptor antagonist
R A Gabel, S D Kivlighn, G J Zingaro, et al.
The American Journal of Physiology
|
March 11, 1995
Discovery of L-162,313: a nonpeptide that mimics the biological actions of angiotensin II
S D Kivlighn, W R Huckle, G J Zingaro, et al.
Journal of Pharmacological and Toxicological Methods
|
July 24, 2007
A highly sensitive canine telemetry model for detection of QT interval prolongation: studies with moxifloxacin, haloperidol and MK-499
A A Chaves, G J Zingaro, M A Yordy, et al.
Journal of Medicinal Chemistry
|
September 15, 1995
Potent and orally active angiotensin II receptor antagonists with equal affinity for human AT1 and AT2 subtypes
L L Chang, W T Ashton, K L Flanagan, et al.
American Journal of Hypertension
|
January 1, 1995
In vivo pharmacology of a novel AT1 selective angiotensin II receptor antagonist, MK-996
S D Kivlighn, G J Zingaro, R A Gabel, et al.
Journal of Medicinal Chemistry
|
December 24, 1993
Non-peptide angiotensin II receptor antagonists. 2. Design, synthesis, and biological activity of N-substituted (phenylamino)phenylacetic acids and acyl sulfonamides
D S Dhanoa, S W Bagley, R S Chang, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
December 1, 1995
Pharmacology of L-754,142, a highly potent, orally active, nonpeptidyl endothelin antagonist
D L Williams, K L Murphy, N A Nolan, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 14) with videos related to
Sort By:
Page
of 2
Neuroscience Letters
|
June 30, 1986
Rat atriopeptin III alters hypothalamic neuronal activity
J T Haskins, G J Zingaro, R W Lappe
Brain Research
|
May 16, 1988
The development of orientation and direction selectivity in the rabbit visual cortex
A M Grigonis, G J Zingaro, E H Murphy
Proceedings of the National Academy of Sciences of the United States of America
|
November 1, 1988
BRL 34915 (cromakalim) activates ATP-sensitive K+ current in cardiac muscle
M C Sanguinetti, A L Scott, G J Zingaro, et al.
Clinical and Experimental Hypertension (New York, N.Y. : 1993)
|
August 1, 1995
In vivo pharmacology of L-159,913, a new highly potent and selective nonpeptide angiotensin II receptor antagonist
R A Gabel, S D Kivlighn, G J Zingaro, et al.
The American Journal of Physiology
|
March 11, 1995
Discovery of L-162,313: a nonpeptide that mimics the biological actions of angiotensin II
S D Kivlighn, W R Huckle, G J Zingaro, et al.
Journal of Pharmacological and Toxicological Methods
|
July 24, 2007
A highly sensitive canine telemetry model for detection of QT interval prolongation: studies with moxifloxacin, haloperidol and MK-499
A A Chaves, G J Zingaro, M A Yordy, et al.
Journal of Medicinal Chemistry
|
September 15, 1995
Potent and orally active angiotensin II receptor antagonists with equal affinity for human AT1 and AT2 subtypes
L L Chang, W T Ashton, K L Flanagan, et al.
American Journal of Hypertension
|
January 1, 1995
In vivo pharmacology of a novel AT1 selective angiotensin II receptor antagonist, MK-996
S D Kivlighn, G J Zingaro, R A Gabel, et al.
Journal of Medicinal Chemistry
|
December 24, 1993
Non-peptide angiotensin II receptor antagonists. 2. Design, synthesis, and biological activity of N-substituted (phenylamino)phenylacetic acids and acyl sulfonamides
D S Dhanoa, S W Bagley, R S Chang, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
December 1, 1995
Pharmacology of L-754,142, a highly potent, orally active, nonpeptidyl endothelin antagonist
D L Williams, K L Murphy, N A Nolan, et al.
Page
of 2